Feasibility and clinical decision-making with 3D echocardiography in routine practice

Heart

Volumn 94, Issue 4, 2008, Pages 440-445

  Hare, J L ^a   Jenkins, C ^a   Nakatani, S ^b   Ogawa, A ^b   Yu, C M ^c   Marwick, T H ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PRACTICE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEASIBILITY STUDY; HEART ARRHYTHMIA; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE VOLUME; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MEDICAL INSTRUMENTATION; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TRANSDUCER;

ADULT; AGED; DECISION MAKING; ECHOCARDIOGRAPHY, THREE-DIMENSIONAL; FEASIBILITY STUDIES; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 41149156955     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2007.123570     Document Type: Article

References (29)

1. White HD, Norris RM, Brown MA, et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44-51.
2. Wang TJ, Evans JC, Benjamin EJ, et al. Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation 2003;108:977-82.
3. Yu CM, Bleeker GB, Fung JW, et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronisation therapy. Circulation 2005;112:1580-6.
4. Jenkins C, Bricknell K, Hanekom L, et al. Reproducibility and accuracy of echocardiographic measurements of left ventricular parameters using real-time three-dimensional echocardiography. J Am Coll Cardiol 2004;44:878-86.
5. Monaghan MJ. Role of real time 3D echocardiography in evaluating the left ventricle. Heart 2006;92:131-6.
6. Van den Bosch AE, Robbers-Visser D, Krenning BJ, et al. Real-time transthoracic three-dimensional echocardiographic assessment of left ventricular volume and ejection fraction in congenital heart disease. J Am Soc Echocardiogr 2006;19:1-6.
7. Chan J, Jenkins C, Khafagi F, et al. What is the optimal clinical technigue for measurement of left ventricular volume after myocardial infarction? A comparative study of 3-dimensional echocardiography, single photon emission computed tomography, and cardiac magnetic resonance imaging. J Am Soc Echocardiogr 2006;19:192-201.
8. Salehian O, Chan KL. Impact of three-dimensional echocardiography in valvular heart disease. Curr Opin Cardiol 2005;20:122-6.
9. Spicer D, Marwick TH. Three-dimensional echocardiography: research toy or clinical tool? Heart Lung Circ 2000;9:98-107.
10. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.
11. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death - executive summary: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006;48:1064-108.
12. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 1992;327:669-77.
13. Smith SC Jr, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006;113:2363-72.
14. Borow KM, Green LH, Mann T, et al. End-systolic volume as a predictor of postoperative left ventricular performance in volume overload from valvular regurgitation. Am J Med 1980;68:655-63.
15. Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006;114:e84-231.
16. Starling MR. Effects of valve surgery on left ventricular contractile function in patients with long-term mitral regurgitation. Circulation 1995;92:811-8.
17. Siemienczuk D, Greenberg B, Morris C, et al. Chronic aortic insufficiency: factors associated with progression to aortic valve replacement. Ann Intern Med 1989;110:587-92.
18. Burns RJ, Gibbons RJ, Yi Q, et al. The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol 2002;39:30-6.
19. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63.
20. Jacobs LD, Salgo IS, Goonewardena S, et al. Rapid online quantification of left ventricular volume from real-time three-dimensional echocardiographic data. Eur Heart J 2006;27:460-8.
21. Caiani EG, Corsi C, Zamorano J, et al. Improved semiautomated quantification of left ventricular volumes and ejection fraction using 3-dimensional echocardiography with a full matrix-array transducer: comparison with magnetic resonance imaging. J Am Soc Echocardiogr 2005;18:779-88.
22. Sugeng L, Mor-Avi V. Weinert L, et al. Quantitative assessment of left ventricular size and function: side-by-side comparison of real-time three-dimensional echocardiography and computed tomography with magnetic resonance reference. Circulation 2006;114:654-61.
23. Kuhl HP, Schreckenberg M, Rulands D, et al. High-resolution transthoracic real-time three-dimensional echocardiography: quantitation of cardiac volumes and function using semi-automatic border detection and comparison with cardiac magnetic resonance imaging. J Am Coll Cardiol 2004;43:2083-90.
24. Jenkins C, Chan J, Hanekom L, et al. Accuracy and feasibility of online 3-dimensional echocardiography for measurement of left ventricular parameters. J Am Soc Echocardiogr 2006;19:1119-28.
25. Akinboboye O, Sumner J, Gopal A, et al. Visual estimation of ejection fraction by two-dimensional echocardiography: the learning curve. Clin Cardiol 1995;18:726-9.
26. Dujardin KS, Enriquez-Sarano M, Rossi A, et al. Echocardiographic assessment of left ventricular remodeling: are left ventricular diameters suitable tools? J Am Coll Cardiol 1997;30:1534-41.
27. St John Sutton M. Predictors of long-term survival after valve replacement for chronic aortic regurgitation. Eur Heart J 2001;22:808-10.
28. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-40.
29. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA 1995;273:1450-6.